Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn's disease

被引：0

作者：

Matar, M. ^{[1
,2
]}

Shamir, R. ^{[1
,2
]}

Turner, D. ^{[3
,4
]}

Broide, E. ^{[5
]}

Weiss, B. ^{[6
]}

Ledder, O. ^{[3
,4
]}

Guz-Mark, A. ^{[1
,2
]}

Rinawi, F. ^{[1
,2
]}

Cohen, S. ^{[7
]}

Olivestone, C. Topf ^{[8
]}

Shaul, R. ^{[9
]}

Ben-Horin, S. ^{[10
]}

Assa, A. ^{[1
,2
]}

机构：

[1] Schneider Childrens Hosp, Petah Tiqwa, Israel

[2] Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel

[3] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Jerusalem, Israel

[4] Juliet Keidan Inst Pediat Gastroenterol, Jerusalem, Israel

[5] Shamir Assaf Harofeh Med Ctr, Pediat Gastroenterol Unit, Zerifin, Israel

[6] Edmond & Lily Safra Childrens Hosp, Pediat Gastroenterol Unit, Ranat Gan, Israel

[7] Dana Dwek Childrens Hosp, Tel Aviv Sourasky Med Ctr, Pediat Gastroenterol Unit, Tel Aviv, Israel

[8] Kaplan Med Ctr, Pediat Gastroenterol Unit, Rehovot, Israel

[9] Rambam Med Ctr, Pediat Gastroenterol Unit, Haifa, Israel

[10] Sheba Med Ctr, Dept Gastroenterol, Ramat Gan, Israel

来源：

JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P718

引用

页码：S578 / S579

页数：2

共 50 条

[31] Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease
Kwak, Min Seob
Kim, Kyung-Jo
Cheon, Jae Hee
Kim, Wan Soo
Lee, Jeong-Mi
Hwang, Sung Wook
Park, Sang Hyoung
Yang, Dong-Hoon
Ye, Byong Duk
Byeon, Jeong-Sik
Myung, Seung-Jae
Yang, Suk-Kyun
GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
[32] Adalimumab Therapy in Children With Crohn Disease Previously Treated With Infliximab
Cozijnsen, Martinus
Duif, Vera
Kokke, Freddy
Kindermann, Angelika
van Rheenen, Patrick
de Meij, Tim
Schaart, Maaike
Damen, Gerard
Norbruis, Obbe
Pelleboer, Rolf
Van den Neucker, Anita
van Wering, Herbert
Hummel, Thalia
Oudshoorn, Johanna
Escher, Johanna
de Ridder, Lissy
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2015, 60 (02): : 205 - 210
[33] Adalimumab maintenance therapy is cost effective for maintaining remission in patients with Crohn's disease
Feagan, Brian
Loftus, Edward
Johnson, Scott
Wu, Eric
Yu, Andrew
Chao, Jingdong
Mulani, Parvez
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S383 - S383
[34] A switch to infliximab may be more effective than ustekinumab following adalimumab pharmacodynamic failure in pediatric patients with Crohn's disease
Driban, G.
Matar, M.
Lev-Tzion, R.
Ledder, O.
Granot, M.
Yerushalmy-Feler, A.
Magen-Rimon, R.
Zifman, E.
Turner, D.
Assa, A.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1774 - i1774
[35] Adalimumab for the treatment of Crohn's disease
Cassinotti, Andrea
Ardizzone, Sandro
Porro, Gabriele Bianchi
BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 763 - 777
[36] Adalimumab for the treatment of Crohn's disease
Devlin, Shane M.
Panaccione, Remo
EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (07) : 1011 - 1019
[37] Pharmacokinetics of adalimumab in Crohn’s disease
David Ternant
Konstantinos Karmiris
Severine Vermeire
Céline Desvignes
Nicolas Azzopardi
Theodora Bejan-Angoulvant
Gert van Assche
Gilles Paintaud
European Journal of Clinical Pharmacology, 2015, 71 : 1155 - 1157
[38] Efficacy and safety of adalimumab in the treatment of Crohn's disease in children
Manuel Navas-Lopez, Victor
Blasco-Alonso, Javier
Giron-Fernandez-Crehuet, Francisco
Juliana Serrano-Nieto, Maria
Sierra-Salinas, Carlos
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (10) : 579 - 584
[39] Adalimumab in pediatric Crohn's disease
Patel, Ashish S.
Suarez, Lisbet D.
Rosh, Joel R.
IMMUNOTHERAPY, 2016, 8 (02) : 127 - 133
[40] Adalimumab induction for Crohn's disease
Cottone, M
Mocciaro, F
Scimeca, D
GASTROENTEROLOGY, 2006, 130 (06) : 1929 - 1929

← 1 2 3 4 5 →